Author:
Yang Szu-Ting,Cheng Min,Lee Na-Rong,Chang Wen-Hsun,Lee Yi-Le,Wang Peng-Hui
Funder
Taipei Veterans General Hospital
Ministry of Science and Technology
Subject
Obstetrics and Gynaecology
Reference19 articles.
1. Safety and efficacy of neoadjuvant chemotherapy with bevacizumab in advanced-stage peritoneal/ovarian cancer patients;Kusunoki;Taiwan J Obstet Gynecol,2018
2. Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer;Wang;Taiwan J Obstet Gynecol,2018
3. The role of α2,3-linked sialylation on clear cell type epithelial ovarian cancer;Sung;Taiwan J Obstet Gynecol,2018
4. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial;Katsumata;Lancet Oncol,2013
5. Weekly vs. every-3-week paclitaxel and carboplatin for ovarian cancer;Chan;N Engl J Med,2016
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献